Your browser doesn't support javascript.
loading
Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes.
Szekeres, Zsolt; Sandor, Barbara; Bognar, Zita; Ramadan, Fadi H J; Palfi, Anita; Bodis, Beata; Toth, Kalman; Szabados, Eszter.
  • Szekeres Z; Division of Preventive Cardiology and Rehabilitation, 1st Department of Medicine, Medical School, University of Pecs, 7624 Pecs, Hungary.
  • Sandor B; Division of Preventive Cardiology and Rehabilitation, 1st Department of Medicine, Medical School, University of Pecs, 7624 Pecs, Hungary.
  • Bognar Z; Department of Biochemistry and Medical Chemistry, University of Pecs, Medical School, 7624 Pecs, Hungary.
  • Ramadan FHJ; Department of Biochemistry and Medical Chemistry, University of Pecs, Medical School, 7624 Pecs, Hungary.
  • Palfi A; Division of Preventive Cardiology and Rehabilitation, 1st Department of Medicine, Medical School, University of Pecs, 7624 Pecs, Hungary.
  • Bodis B; Division of Endocrinology and Metabolism, 1st Department of Medicine, Medical School, University of Pecs, 7624 Pecs, Hungary.
  • Toth K; Division of Cardiology, 1st Department of Medicine, Medical School, University of Pecs, 7624 Pecs, Hungary.
  • Szabados E; Division of Preventive Cardiology and Rehabilitation, 1st Department of Medicine, Medical School, University of Pecs, 7624 Pecs, Hungary.
Int J Mol Sci ; 24(5)2023 Feb 23.
Article en En | MEDLINE | ID: mdl-36901837
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article